GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

65 hedge funds and large institutions have $58.6M invested in Galectin Therapeutics in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 13 closing their positions.

Holders
65
Holders Change
+10
Holders Change %
+18.18%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
22
Reduced
12
Closed
13
Calls
$1.92M
Puts
$3.46M
Net Calls
-$1.55M
Net Calls Change
+$3.75M

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$11M
2
BFA
2
BlackRock Fund Advisors
California
$6.26M
3
BIT
3
BlackRock Institutional Trust
California
$2.78M
4
State Street
4
State Street
Massachusetts
$2.35M
5
TCIM
5
TIAA CREF Investment Management
New York
$914K

Top Sellers

1
MP
1
Mangrove Partners
Connecticut
$0
2
BBA
2
Baker Bros. Advisors
New York
$4.14M
3
EI
3
EAM Investors
California
$0
4
DCM
4
Driehaus Capital Management
Illinois
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.67M
Name Market Value Shares Shares
Change 		Shares
Change %
BG
76
BlackRock Group
United Kingdom
– – -4,727 Closed
QT
77
Quantbot Technologies
New York
– – -2,000 Closed
TC
78
TradeLink Capital
Illinois
– – -1,200 Closed
ST
79
Spot Trading
Illinois
– – – –
1 2 3
4